Serum testosterone levels in non-dosed females after secondary exposure to 1.62% testosterone gel: effects of clothing barrier on testosterone absorption

References

• Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-31 [PubMed: 11158037]
   PubMed Web of Science ®Google Scholar
• Liverman C, Balzer D, eds. Testosterone and Aging: Clinical Research Directions/Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy, Board on Health Sciences Policy Washington, DC: The National Academies Press, 2004
   Google Scholar
• McNicholas TA, Dean JD, Mulder H, et al. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 2003;91:69-74 [PubMed: 12614254]
   PubMed Web of Science ®Google Scholar
• Steidle C, Schwartz S, Jacoby K, et al. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 2003;88:2673-81 [PubMed: 12788872]
   PubMed Web of Science ®Google Scholar
• Swerdloff RS, Wang C, Cunningham G, et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 2000;85:4500-10 [PubMed: 11134099]
   PubMed Web of Science ®Google Scholar
• Wang C, Cunningham G, Dobs A, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2085-98 [PubMed: 15126525]
   PubMed Web of Science ®Google Scholar
• Wang C, Swerdloff RS, Iranmanesh A, et al. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf) 2001;54:739-50 [PubMed: 11422108]
   PubMed Web of Science ®Google Scholar
• Rolf C, Knie U, Lemmitz G, Nieschlag E. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation. Clin Endocrinol (Oxf) 2002;56:637-41 [PubMed: 12030915]
   PubMed Web of Science ®Google Scholar
• Bhowmick SK, Ricke T, Rettig KR. Sexual precocity in a 16-month-old-boy induced by indirect topical exposure to testosterone. Clin Pediatr (Phila) 2007;46:540-3 [PubMed: 17579107]
   PubMed Web of Science ®Google Scholar
• de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies. Hum Reprod 2009;24:425-8 [PubMed: 18948313]
   PubMed Web of Science ®Google Scholar
• Merhi ZO, Santoro N. Postmenopausal virilization after spousal use of topical androgens. Fertil Steril 2007;87:976.e13-15 [PubMed: 17254577]
   PubMed Web of Science ®Google Scholar
• Mazer N, Fisher D, Fischer J, et al. Transfer of transdermally applied testosterone to clothing: a comparison of a testosterone patch versus a testosterone gel. J Sex Med 2005;2:227-34 [PubMed: 16422890]
   PubMed Web of Science ®Google Scholar
• Kaufman JM, Miller MG, Garwin JL, et al. Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men. J Sex Med 2011;8:2079-89 [PubMed: 21492400]
   PubMed Web of Science ®Google Scholar
• Miller J, Britto M, Fitzpatrick S, et al. Pharmacokinetics and relative bioavailability of absorbed testosterone after administration of a 1.62% testosterone gel to different application sites in men with hypogonadism. Endocr Pract 2011;17:574-83 [PubMed: 21454244]
   PubMed Web of Science ®Google Scholar
• Mayo Clinic Medical Laboratories. Clinical reference ranges for measurement of serum testosterone using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) methods. Rochester, MN: Mayo Foundation for Medical Education and Research. Available at: http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/8533 [Last accessed 6 January 2012]
   Google Scholar
• Stahlman J, Britto M, Fitzpatrick S, et al. Effect of application site, clothing barrier and application site washing on testosterone transfer with a 1.62% testosterone gel. Curr Med Res Opin; 2012;28:281-90
   Google Scholar
• Brachet C, Vermeulen J, Heinrichs C. Children’s virilization and the use of a testosterone gel by their fathers. Eur J Pediatr 2005;164:646-7 [PubMed: 16025298]
   PubMed Web of Science ®Google Scholar
• Kunz GJ, Klein KO, Clemons RD, et al. Virilization of young children after topical androgen use by their parents. Pediatrics 2004;114:282-4 [PubMed: 15231947]
   PubMed Web of Science ®Google Scholar
• Yu YM, Punyasavatsu N, Elder D, D’Ercole AJ. Sexual development in a two-year-old boy induced by topical exposure to testosterone. Pediatrics 1999;104:e23 [PubMed: 10429141]
   PubMed Web of Science ®Google Scholar
• Delanoe D, Fougeyrollas B, Meyer L, Thonneau P. Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet 1984;1:276 [PubMed: 6143012]
   Google Scholar
• Busse KL, Maibach HI. Transdermal estradiol and testosterone transfer in man: existence, models, and strategies for prevention. Skin Pharmacol Physiol 2011;24:57-66 [PubMed: 21088452]
   PubMed Web of Science ®Google Scholar
• Testim 1% (testosterone gel) [prescribing information]. Malvern, PA: Auxilium Pharmaceuticals Inc., 2009
   Google Scholar
• Fortesta (testosterone) gel [prescribing information]. Chadds Ford, PA, USA: Endo Pharmaceuticals Inc., 2010
   Google Scholar
• Axiron (testosterone) topical solution [prescribing information]. Indianapolis, IN, USA: Lilly USA LLC, 2010
   Google Scholar
• Stahlman J, Britto M, Fitzpatrick S, et al. The effects of skin washing on the systemic absorption of testosterone in hypogonadal males after administration of a 1.62% testosterone gel. Curr Med Res Opin; 2012;28:271-9
   Google Scholar